NCT00007839View on ClinicalTrials.gov

Beta Alethine in Treating Patients With Low-Grade Lymphoma

PHASE1/PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Conditions
Lymphoma
Interventions
DRUG

beta alethine

Trial Locations (1)

20852

Victory Over Cancer, Rockville

Sponsors
All Listed Sponsors
lead

LifeTime Pharmaceuticals

INDUSTRY

NCT00007839 - Beta Alethine in Treating Patients With Low-Grade Lymphoma | Biotech Hunter | Biotech Hunter